Chris Tudan - Director of Quality Assurance

"The Veloxity team are not only highly skilled and proficient bioanalytical scientists, they also have a great understanding of the requirements of drug development, are not afraid to ask questions, are excellent and proactive communicators and ensure that they deliver data to a high standard, on-time. I have been actively working in partnership with the Veloxity team on a project for a Client, that involves the analysis of pharmacokinetic samples derived from a novel patient centric blood sample collection technology. The aim of the approach is to enable sampling from children in their own home for a late phase clinical program. The Veloxity team have been wonderful partners in discussing what validation experiments to perform for these novel sample types, which are not necessarily covered by current bioanalytical validation and sample analysis guidelines. Through this, the team delivered high quality GxP assay validations for 3 sample matrices to a very tight timeframe, enabling a clinical study to proceed. The Veloxity team were then proactive in their interactions with the clinical study team, which involved a number of different entities. Following the timely analysis of the clinical study samples, the Veloxity team were actively involved in discussions around the data obtained and what factors may need to be further investigated.